Efficacy and safety of atrial fibrillation ablation in patients with aged 80 years or older

Atrial fibrillation (AF) is the most common cardiac arrhythmia observed in the elderly. Its prevalence rises with age, particularly in individuals over 80 years old. While catheter ablation has emerged as a first line therapy for the patients with symptomatic AF, evidence on its application in elder...

Full description

Saved in:
Bibliographic Details
Published in:Heart and vessels 2024-09
Main Authors: Yodogawa, Kenji, Iwasaki, Yu-Ki, Ito, Nobuaki, Arai, Toshiki, Hachisuka, Masato, Fujimoto, Yuhi, Hagiwara, Kanako, Murata, Hiroshige, Aizawa, Yoshiyasu, Shimizu, Wataru, Asai, Kuniya
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Atrial fibrillation (AF) is the most common cardiac arrhythmia observed in the elderly. Its prevalence rises with age, particularly in individuals over 80 years old. While catheter ablation has emerged as a first line therapy for the patients with symptomatic AF, evidence on its application in elderly patients remains controversial. This study aimed to assess safety and efficacy outcomes of AF ablation in patients aged ≥ 80 years. Consecutive 1327 patients who underwent a first pulmonary vein isolation (PVI) for AF were retrospectively analyzed. Patients aged ≥ 80 years (elderly group, n = 107) were compared with patients aged 
ISSN:0910-8327
1615-2573
1615-2573
DOI:10.1007/s00380-024-02458-7